戻る Agenda
Session 6: Am I Compliant Enough?
Session Chair(s)
Angela Van Der Salm, PHD, MSC
Director PV, Managing partner, DADA Consultancy B.V., Netherlands
Elspeth McIntosh, MBA, RN
Director, Castle Pharmacovigilance Ltd, United Kingdom
The actions required to demonstrate compliance may vary depending on company size, products and complexity of processes. This session will look at challenges and potential solutions for small/medium sized companies across a range of activities which affect QPPV oversight.
Speaker(s)
Peter De Veene, MD
QPPV, MSD Belgium, Belgium
International Infrastructure Challenges (Small vs Large Company)
Angela Van Der Salm, PHD, MSC
Director PV, Managing partner, DADA Consultancy B.V., Netherlands
Small Pharma Challenges and Outsourcing
Martijn Van De Leur
Chief Commercial Officer, Biomapas, Lithuania
Challenges in Compliance and Audits
David Stokes
Director and Principal Consultant, Convalido, United Kingdom
Challenges in Computer System Validation